TriSalus Life Sciences, Inc. (TLSIW) Free cash flow 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.9MFY2025 · since FY2022: -$33.0M → -$18.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.9M | +54.0% |
| FY2024 | -$41.2M | +19.5% |
| FY2023 | -$51.2M | -55.2% |
| FY2022 | -$33.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice